ViaLase Inc. announced a research partnership with the John A. Moran Eye Center at the University of Utah, home to the Alan S. Crandall Center for Glaucoma Innovation. The collaboration will investigate the aqueous outflow dynamics of ViaLase’s novel laser procedure, using Moran's advanced iPerfusion technology.The ViaLase laser procedure delivers precise femtosecond laser … [Read more...] about ViaLase, John A. Moran Eye Center unveil research partnership to spark glaucoma research, innovation
News
IL-6 and its role in thyroid eye disease
In an interview with Ophthalmology Times, Alon Kahana, MD, PhD, discussed interleukin-6 (IL-6), a signaling molecule crucial in regulating the immune system and its role in autoimmune diseases, particularly thyroid eye disease (TED). IL-6 influences T cells, B cells, and inflammatory cells, driving immune processes that can be beneficial in infections but harmful in autoimmune … [Read more...] about IL-6 and its role in thyroid eye disease
Laru-zova shows safety, low luminance visual acuity gains in X-linked retinitis pigmentosa
December 10, 2024 1 min read Laru-zova demonstrated a positive safety profile and early efficacy in improving low luminance visual acuity in patients with X-linked retinitis pigmentosa, according to a presentation at the FLORetina-ICOOR meeting. “These data show promising early improvements in low luminance visual acuity (LLVA) and may … [Read more...] about Laru-zova shows safety, low luminance visual acuity gains in X-linked retinitis pigmentosa
Post hoc analysis of PULSAR data shows sustained fluid control with Eylea HD
December 10, 2024 1 min read BARCELONA, Spain — A post hoc analysis of PULSAR trial data showed sustained fluid control at 2 years with fewer injections and longer dosing intervals in patients treated with aflibercept 8 mg for wet age-related macular degeneration. “We also saw higher proportions of patients with fluid resolution observed with … [Read more...] about Post hoc analysis of PULSAR data shows sustained fluid control with Eylea HD
Part 7: Advice from the experts: Helpful information for current residents
In this series, experts in the field advise current residents and offer insight into how they can make the most of their time and experience moving forward with their careers.Video Transcript:Editor's note: The below transcript has been lightly edited for clarity.Kamran Riaz, MD:What advice would I give to our resident today is, I think, really embrace the word 'reside'. I know … [Read more...] about Part 7: Advice from the experts: Helpful information for current residents
Survey highlights gender and racial disparities in ophthalmology
Investigators from The Vision Center at the Children’s Hospital Los Angeles, and the Roski Eye Institute, Keck School of Medicine, University of Southern California, both in Los Angeles, reported that, based on their recent study, discrimination is prevalent among US ophthalmologists, with gender-based discrimination being reported most frequently.The study was led by first … [Read more...] about Survey highlights gender and racial disparities in ophthalmology
VIDEO: Patients need ‘fair and equitable access’ to TearCare
December 10, 2024 3 min watch CHICAGO — In this Healio Video Perspective from the AAO meeting, Neel R. Desai, MD, of The Eye Institute of West Florida discusses the positive impact of the TearCare system on ocular surface disease and meibomian gland dysfunction. “With TearCare-targeted thermal care, we know that we have a tremendous … [Read more...] about VIDEO: Patients need ‘fair and equitable access’ to TearCare
Nona Biosciences and Kodiak Sciences partner to develop novel antibodies for ophthalmic diseases
Nona Biosciences has announced a strategic collaboration with Kodiak Sciences Inc. aimed at advancing the discovery of innovative multi-target antibodies for the treatment of ophthalmic diseases. This partnership will utilize Nona's proprietary Harbour Mice platform, a technology for generating fully human antibodies.The Harbour Mice platform is capable of producing fully human … [Read more...] about Nona Biosciences and Kodiak Sciences partner to develop novel antibodies for ophthalmic diseases
Diagnostic Maze: Navigating the complexity of isolated optic disc edema in syphilitic uveitis
A resurgence of syphilis has brought renewed attention to ocular syphilis, a condition with a broad range of manifestations that can mimic other ocular and systemic diseases. With cases of syphilitic uveitis on the rise, recognizing its varied presentations—including optic disc edema, which may appear without other significant eye inflammation—is increasingly important for … [Read more...] about Diagnostic Maze: Navigating the complexity of isolated optic disc edema in syphilitic uveitis
Beacon Therapeutics announces positive 3-month data from Phase 2 DAWN trial of AGTC-501 in patients with X-linked retinitis pigmentosa
Beacon Therapeutics presented 3-month interim safety and efficacy data from the Phase 2 DAWN trial of laru-zova (AGTC-501) for X-linked retinitis pigmentosa (XLRP) at the FLORetina ICOOR 2024 meeting in Florence, Italy.According to the company, the data show early promise in improving low luminance visual acuity (LLVA), a key measure of visual function in patients with this … [Read more...] about Beacon Therapeutics announces positive 3-month data from Phase 2 DAWN trial of AGTC-501 in patients with X-linked retinitis pigmentosa